Company / Net Debt per Share
Gilead Sciences Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$20.01
FY2025
5-year range
$17.03 / $21.44
FY2021-FY2025
Trend
-6.6%
vs FY2024
Sector context
#11 of 82
Health Care
What the data says
Gilead Sciences's net debt per share of $20.01 is higher than 87% of companies in the Health Care sector (FY2025). Net Debt per Share has fluctuated over the past 10 years, ranging from $8.16 in FY2019 to $21.44 in FY2024.
Based on SEC 10-K filings.
20.01 in FY2025 with a 5-year CAGR of -0.1%. Top quartile in the Health Care sector.
Remained stable around $20.01 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -0.2%
- 5-Year CAGR
- -0.1%
- 10-Year CAGR
- -
Sector benchmark
+46.1% above sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 6.6% year-over-year.
- Ranks #11 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2024.
- Lowest net debt per share in the period was in FY2019.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.01 | -6.6% |
| FY2024 | $21.44 | +7.0% |
| FY2023 | $20.04 | -0.4% |
| FY2022 | $20.12 | +18.1% |
| FY2021 | $17.03 | -15.1% |
| FY2020 | $20.07 | +145.9% |
| FY2019 | $8.16 | -37.2% |
| FY2018 | $12.99 | -5.2% |
| FY2017 | $13.70 | +19.4% |
| FY2016 | $11.48 | +84.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026